title: Shifting emphasis from pharmacogenomics to theragnostics.
authors.affiliation: Biomarker and Clinical Pharmacology Unit, VA Long Beach Healthcare System, Southern California Institute for Research and Education, University of California, Irvine, CA, USA. vural.ozdemir@med.va.gov
authors.forename: Vural
authors.initials: V
authors.lastname: Ozdemir
authors.forename: Bryn
authors.initials: B
authors.lastname: Williams-Jones
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Glatt
authors.forename: Ming T
authors.initials: MT
authors.lastname: Tsuang
authors.forename: James B
authors.initials: JB
authors.lastname: Lohr
authors.forename: Christopher
authors.initials: C
authors.lastname: Reist
mesh_terms: D016503:Drug Delivery Systems / Q000379:methods*; D015195:Drug Design; D004358:Drug Therapy / Q000379:methods / Q000639:trends; D010597:Pharmacogenetics / Q000379:methods* / Q000639:trends*